NewsAvi Kapoor
BioLife Solutions
BLFS · NASDAQ
Price unavailable right now.
No price history for this range.
Latest news
- Press releaseGlobe Newswire
Repligen Completes Acquisition of BioLife Solutions
- Press releasePRNewswire
Freshworks Set to Join S&P SmallCap 600
- Press releasePRNewswire
Are BLFS, FTHM, AUUD, VRME Obtaining Fair Deals for their Shareholders?
- Press releaseBusiness Wire
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
- Press releaseBusiness Wire
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
- Press releasePRNewswire
BioLife Solutions Reports Second Quarter 2026 Financial Results
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWD
- Press releasePRNewswire
Are NG, BLFS, NRIM Obtaining Fair Deals for their Shareholders?
- Press releaseBusiness Wire
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
- Press releasePRNewswire
Are UTZ, BLFS, FNWD Obtaining Fair Deals for their Shareholders?
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (NASDAQ: BLFS)
- Press releasePRNewswire
Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price for Public Shareholders
- NewsVandana Singh
Repligen Strengthens Cell Therapy Portfolio With BioLife Acquisition
- Press releaseBusiness Wire
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
- News
BioLife Solutions To Be Acquired By Repligen For $31 Per Share In Cash And RGEN Stock At EV Of ~$1.5B
- Press releaseGlobe Newswire
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
- Press releasePRNewswire
BioLife Solutions Reports First Quarter 2026 Financial Results
- Press releasePRNewswire
BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
- Press releasePRNewswire
BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCase
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
BioLife Solutions Earnings Report: Q4 Overview
- Press releasePRNewswire
BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations
- Press releasePRNewswire
BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026
- Press releasePRNewswire
BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market
- Press releasePRNewswire
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations
- Press releasePRNewswire
BioLife Solutions Unveils the Aby J. Mathew Center for Biopreservation Excellence
- Press releasePRNewswire
BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025
- Press releasePRNewswire
BioLife Solutions Reports Third Quarter 2025 Financial Results
- News
Earnings Scheduled For November 6, 2025
- Press releasePRNewswire
BioLife Solutions to Report Third Quarter 2025 Financial Results and Business Update on November 6, 2025
- Press releasePRNewswire
BioLife Solutions Announces the Sale of its evo Cold Chain Logistics Subsidiary
- Press releasePRNewswire
BioLife Solutions Reports Second Quarter 2025 Financial Results
- News
Earnings Scheduled For May 8, 2025
- News
Analyst Expectations For BioLife Solns's Future
- Press releasePRNewswire
BioLife Solutions Reports Third Quarter 2024 Financial Results
- Press releasePRNewswire
BioLife Solutions Reports Second Quarter 2024 Financial Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.